Michigan Craft Beverage Conference planned; two Coffee with Corn webinars remaining; Dairy Business Builder Grants available.
4 天on MSN
Arcturus outlines 12-week Phase II CF trial launch and expects regulatory clarity for ARCT ...
Q4 2025 Management View CEO Joseph Payne provided an update on the ARCT-032 and ARCT-810 programs, stating the ARCT-032 Phase II trial is progressing with higher dose testing at 15 milligrams in 4 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果